+254.2%
MRNA vs AVAV
+1.8%
+252.4%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | AVAV | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.9% | +0.7% | -1.6% | -1.0% |
| 7D | -3.8% | +9.9% | -13.6% | -5.1% |
| 30D | +16.4% | -5.4% | +21.8% | +16.8% |
| 3M | +310.6% | -36.5% | +347.1% | +337.8% |
| 6M | +370.3% | -25.3% | +395.6% | +386.0% |
| YTD | +743.3% | -48.6% | +791.9% | +793.5% |
| 1Y | +841.7% | -62.1% | +903.7% | +931.9% |
| All | +254.2% | +1.8% | +252.4% | +240.4% |
Cumulative growth
Daily Returns
Daily percentage return beside AVAV.
Daily Out/Under-Performance
Portfolio return minus AVAV return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × AVAV return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded AVAV wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling